Good news: Medox has been awarded the title of "Zhejiang Provincial Industrial New Product"

Recently, the medical molecular sieve oxygen concentrator declared by the company has successfully passed the provincial-level industrial new product appraisal in Zhejiang Province. The company always adheres to customer needs as the guide, continuously carries out technological innovation, constantly develops and rapidly iterates technology and products, accurately meets customer needs, and better helps customers achieve business goals. At the same time, the certification of new industrial products (new technologies) in Zhejiang Province is not only a powerful example of the company's technological research and development capability, but also further shows that the company is committed to achieving progressiveness, stability and reliability of products through technological innovation and providing differentiated technologies, and continues to create value for society and customers.

The provincial identification of new industrial products (new technologies) organized by the Department of Economy and Information Technology of Zhejiang Province aims to select and support industrial products and technologies with progressiveness, novelty, applicability, potential economic benefits and greater market prospects within the industry.

The medical molecular sieve oxygen concentrator applied for by Medox has effectively compensated for the shortcomings of bottled gas oxygen and liquid oxygen oxygen sources. It has the characteristics of low cost, easy use, and safe operation. The company's product has been deeply researched and designed from the perspective of oxygen production and supply system, realizing real-time remote control and monitoring of the operation status and interlocking start stop of each unit of the oxygen production equipment. It can automatically and seamlessly switch to the busbar oxygen supply in case of power outage or oxygen production machine failure, ensuring the continuity of oxygen supply. At the same time, in order to meet the higher reliability of the equipment, the electromagnetic valve automatically switches between different oxygen sources, greatly improving the reliability of the oxygen supply system.

At the review meeting on August 27th, the expert group listened to the work and technical summary, project development work summary, product testing, technology novelty search, user evaluation report, and other relevant materials of Yixiang. After discussion, the appraisal committee believed that the product declared by Medox not only improved the quality of oxygen supply, but also achieved interconnection and improved the reliability of the oxygen system by directly connecting to the hospital's existing information system. The product related technology has obtained 2 utility model patents, which is at the leading level of similar products in China. The appraisal committee unanimously agreed to pass the appraisal at the review meeting.